IL10 rs1800871: What Your Genotype Means
The rs1800871 variant is a single nucleotide polymorphism located in the promoter region of the IL10 gene. It is frequently studied for its potential role in modulating interleukin-10 expression, which may influence inflammatory responses and susceptibility to various autoimmune and chronic conditions.
What each genotype means
Typical IL-10 promoter profile
This genotype represents the major allele configuration for the IL-10 promoter region. Research into this variant often focuses on how it may influence interleukin-10 expression levels, though findings regarding disease susceptibility are mixed and often depend on specific ancestral backgrounds. This variant is frequently studied alongside other promoter SNPs, and its clinical significance remains an area of ongoing investigation.
This is the most common genotype in many global populations, though frequencies vary significantly by ancestry.
Heterozygous IL-10 promoter variant
Carrying one copy of each allele may result in intermediate promoter activity compared to homozygous states. Some studies have suggested that this genotype might be associated with different outcomes in specific conditions, such as improved survival in certain glioma cases, but these associations are not universal. Because the evidence is limited and context-dependent, this result should not be used to predict individual health outcomes.
This genotype is commonly observed, appearing in a significant portion of individuals across diverse ancestral groups.
Minor allele IL-10 profile
This genotype represents the homozygous minor allele state for the rs1800871 variant. While some research links this polymorphism to altered inflammatory responses or susceptibility to certain cancers in specific populations, the evidence is inconsistent and often varies by ethnicity. It is important to view these findings as statistical associations observed in research studies rather than definitive indicators of personal health risk.
This genotype is less common than the C/C or C/T configurations, with frequencies that fluctuate notably between European and East Asian populations.
Understanding the rs1800871 Variant
The rs1800871 variant is a well-documented single nucleotide polymorphism (SNP) situated within the promoter region of the IL10 gene on chromosome 1. In genetic databases, this variant is often described as a -819C/T polymorphism, referring to its specific position relative to the gene's transcription start site. Because it resides in the promoter—the "control center" of a gene—researchers hypothesize that this change may alter how effectively the body produces the IL-10 protein. By influencing the binding of transcription factors, this SNP is thought to potentially skew the balance of inflammatory signals in the body. While it is a common target for genetic association studies, it is important to note that its functional impact can vary significantly depending on the cellular context and the presence of other nearby genetic variations, which often exist in a state of linkage disequilibrium.
The Role of the IL10 Gene
The IL10 gene encodes Interleukin-10, a critical cytokine that acts as a potent anti-inflammatory mediator. IL-10 plays a vital role in limiting the host immune response to pathogens, thereby preventing excessive tissue damage and maintaining normal tissue homeostasis. By suppressing the production of pro-inflammatory cytokines, IL-10 helps regulate the duration and intensity of immune reactions. Because of its central role in "braking" the immune system, variations in the IL10 gene are frequently investigated in the context of autoimmune diseases, chronic infections, and inflammatory conditions. When the production of IL-10 is altered, it may theoretically shift the immune system toward a more pro-inflammatory state, which is why researchers look at promoter variants like rs1800871 to see if they correlate with differences in serum IL-10 levels or disease outcomes.
Research Associations and Evidence Strength
Research into rs1800871 has produced a complex and often mixed body of evidence. It has been investigated for associations with a wide range of conditions, including systemic lupus erythematosus (SLE), Behçet's disease, cervical cancer, and systemic sclerosis. For instance, some studies have observed correlations between specific genotypes and disease activity or susceptibility in certain ethnic groups. However, the strength of this evidence is generally considered limited. Meta-analyses often show that associations found in one population—such as Han Chinese or Tunisian cohorts—are not always replicated in others, highlighting the influence of genetic background and environmental factors. Because many of these studies are observational and rely on case-control designs, they demonstrate statistical associations rather than direct causation. Consequently, rs1800871 is not currently used as a definitive diagnostic tool, and its clinical utility remains a subject of ongoing scientific inquiry.
Population Frequency
The distribution of the rs1800871 variant varies significantly across global populations. The minor allele frequency is typically observed to be between 0.25 and 0.35 in European ancestries, while it can reach frequencies as high as 0.65 in East Asian populations. This high degree of variability underscores the importance of considering ancestry when interpreting genetic data, as the "common" or "expected" genotype differs depending on one's geographic and ethnic background.
Interpreting Your Genetic Information
If you have received results regarding your rs1800871 genotype, it is important to view this information as a small piece of a much larger biological puzzle. Genetic variants like this are rarely the sole cause of any health condition; rather, they represent minor variations that may slightly influence immune function in combination with many other genes and environmental factors like diet, stress, and lifestyle. You cannot use this information to diagnose yourself or predict future health outcomes with certainty. If you are concerned about inflammatory conditions or immune health, the most effective approach is to consult with a qualified healthcare professional. They can evaluate your overall health, family history, and clinical symptoms to provide appropriate guidance. Never make changes to your medical care or medication regimen based on genetic test results without first discussing them with your doctor or pharmacist.
How common is this variant?
The minor allele frequency for rs1800871 is approximately 0.25-0.35 in European ancestries and up to 0.65 in East Asian populations.
Frequently asked questions
Is rs1800871 a diagnostic test for autoimmune disease?
No, rs1800871 is not a diagnostic test. While it has been studied for associations with various inflammatory conditions, it does not cause these diseases on its own and cannot be used to predict whether an individual will develop a specific health condition.
Does my rs1800871 genotype mean I have low IL-10 levels?
Not necessarily. While some research suggests that promoter variants can influence IL-10 expression, actual protein levels are determined by a complex interplay of genetics, current health status, and environmental factors. A genetic test for this SNP does not measure your actual serum IL-10 levels.
Should I change my medication based on this result?
No. You should never change your medication or treatment plan based on genetic test results without consulting your healthcare provider. Always discuss any concerns about your health or medications with a qualified clinician or pharmacist.
Why do different studies show different results for this SNP?
Genetic associations often vary between populations due to differences in genetic background, environmental exposures, and study design. Because rs1800871 is a common variant, its effects may be subtle and easily influenced by other factors, leading to inconsistent findings across different research groups.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800871?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL10
Regulatory upstream noncoding variant in IL10 that influences anti-inflammatory cytokine production.
The -592C/A variant in the promoter of IL-10 regulates transcription factor binding, impacting cytokine output and risk for inflammatory bowel disease.
Part of the extended IL-10 promoter haplotype influencing differential anti-inflammatory IL-10 cytokine output and susceptibility to graft-versus-host disease.
Functional promoter variant (-1082 A/G) influencing interleukin-10 expression levels and inflammatory disease susceptibility.
Functional regulatory promoter variant in IL10 associated with altered interleukin-10 expression and enhanced susceptibility to dust mite allergic sensitization.
Variant in the interleukin-10 gene interacting with environmental dust mite exposure to significantly alter the risk of allergic sensitization and exacerbations.